Literature DB >> 12466964

Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation.

Stuart S Hobbs1, Stephanie L Coffing, Ann T D Le, Elizabeth M Cameron, Eric E Williams, Michelle Andrew, Erika N Blommel, Robert P Hammer, Han Chang, David J Riese.   

Abstract

During the last decade, several novel members of the Epidermal Growth Factor family of peptide growth factors have been identified. Most prominent among these are the Neuregulins or Heregulins. To date, four different Neuregulin genes have been identified (Neuregulin1-4) and several different splicing isoforms have been identified for at least two of these genes (Neuregulin1 and Neuregulin2). While Neuregulin1 isoforms have been extensively studied, comparatively little is known about Neuregulin3, Neuregulin4, or the Neuregulin2 isoforms. Indeed, there has been no systematic comparison of the activities of these molecules. Here we demonstrate that Neuregulin2alpha and Neuregulin2beta stimulate ErbB3 tyrosine phosphorylation and coupling to biological responses. In contrast, Neuregulin3 and Neuregulin4 fail to activate ErbB3 signaling. Furthermore, Neuregulin2beta, but not Neuregulin2alpha, stimulates ErbB4 tyrosine phosphorylation and coupling to biological responses. Finally, both Neuregulin3 and Neuregulin4 stimulate modest amounts of ErbB4 tyrosine phosphorylation. However, whereas Neuregulin3 stimulates a modest amount of ErbB4 coupling to biological responses, Neuregulin4 fails to stimulate ErbB4 coupling to biological responses. This suggests that there are qualitative as well as quantitative differences in ErbB family receptor activation by Neuregulin isoforms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466964     DOI: 10.1038/sj.onc.1205960

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

1.  The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056.

Authors:  Richard M Gallo; David J Riese
Journal:  Growth Factors       Date:  2007-10       Impact factor: 2.511

2.  The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.

Authors:  Samuel Bouyain; Patti A Longo; Shiqing Li; Kathryn M Ferguson; Daniel J Leahy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

Review 3.  The brown fat secretome: metabolic functions beyond thermogenesis.

Authors:  Guo-Xiao Wang; Xu-Yun Zhao; Jiandie D Lin
Journal:  Trends Endocrinol Metab       Date:  2015-04-02       Impact factor: 12.015

Review 4.  Epiregulin: roles in normal physiology and cancer.

Authors:  David J Riese; Richard L Cullum
Journal:  Semin Cell Dev Biol       Date:  2014-03-12       Impact factor: 7.727

Review 5.  Signalling between microvascular endothelium and cardiomyocytes through neuregulin.

Authors:  Emily M Parodi; Bernhard Kuhn
Journal:  Cardiovasc Res       Date:  2014-01-29       Impact factor: 10.787

6.  The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.

Authors:  Kristy J Wilson; Christopher P Mill; Richard M Gallo; Elizabeth M Cameron; Henry VanBrocklin; Jeffrey Settleman; David J Riese
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

7.  The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.

Authors:  David P Kodack; Vasileios Askoxylakis; Gino B Ferraro; Qing Sheng; Mark Badeaux; Shom Goel; Xiaolong Qi; Ram Shankaraiah; Z Alexander Cao; Rakesh R Ramjiawan; Divya Bezwada; Bhushankumar Patel; Yongchul Song; Carlotta Costa; Kamila Naxerova; Christina S F Wong; Jonas Kloepper; Rita Das; Angela Tam; Jantima Tanboon; Dan G Duda; C Ryan Miller; Marni B Siegel; Carey K Anders; Melinda Sanders; Monica V Estrada; Robert Schlegel; Carlos L Arteaga; Elena Brachtel; Alan Huang; Dai Fukumura; Jeffrey A Engelman; Rakesh K Jain
Journal:  Sci Transl Med       Date:  2017-05-24       Impact factor: 17.956

8.  A high throughput, interactive imaging, bright-field wound healing assay.

Authors:  Michael D Zordan; Christopher P Mill; David J Riese; James F Leary
Journal:  Cytometry A       Date:  2011-02-09       Impact factor: 4.355

Review 9.  Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.

Authors:  Alphonse-E Sirica
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

10.  Expression and purification of HER2 extracellular domain proteins in Schneider2 insect cells.

Authors:  Shanthi Kanthala; Christopher P Mill; David J Riese; Mihir Jaiswal; Seetharama Jois
Journal:  Protein Expr Purif       Date:  2015-09-09       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.